Relay Therapeutics Files 8-K on Shareholder Votes

Ticker: RLAY · Form: 8-K · Filed: Jun 6, 2025 · CIK: 1812364

Relay Therapeutics, Inc. 8-K Filing Summary
FieldDetail
CompanyRelay Therapeutics, Inc. (RLAY)
Form Type8-K
Filed DateJun 6, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, shareholder-vote, 8-k

TL;DR

Relay Therapeutics held a shareholder vote on June 6, 2025. Standard governance filing.

AI Summary

Relay Therapeutics, Inc. filed an 8-K on June 6, 2025, to report on matters submitted to a vote of its security holders. The filing details the company's principal executive offices located at 60 Hampshire Street, Cambridge, Massachusetts, 02139, and its telephone number is (617) 370-8837. The company is incorporated in Delaware and operates in the biological products sector.

Why It Matters

This filing indicates that Relay Therapeutics held a shareholder vote, which is a standard corporate governance event that can impact company direction and shareholder rights.

Risk Assessment

Risk Level: low — This is a routine corporate filing regarding a shareholder vote, not indicating any immediate financial or operational risks.

Key Numbers

  • 001-39385 — SEC File Number (Relay Therapeutics' SEC filing identifier)
  • 47-3923475 — IRS Employer Identification No. (Relay Therapeutics' tax identification number)

Key Players & Entities

  • Relay Therapeutics, Inc. (company) — Registrant
  • June 06, 2025 (date) — Date of earliest event reported
  • 60 Hampshire Street, Cambridge, Massachusetts, 02139 (address) — Principal Executive Offices
  • (617) 370-8837 (phone_number) — Registrant's Telephone Number
  • Delaware (jurisdiction) — State of Incorporation

FAQ

What specific matters were submitted to a vote of security holders by Relay Therapeutics?

The filing states it is a 'Submission of Matters to a Vote of Security Holders' but does not detail the specific proposals voted upon in this excerpt.

When was the earliest event reported in this 8-K filing?

The earliest event reported is dated June 06, 2025.

Where are Relay Therapeutics' principal executive offices located?

Relay Therapeutics' principal executive offices are located at 60 Hampshire Street, Cambridge, Massachusetts, 02139.

What is Relay Therapeutics' telephone number?

Relay Therapeutics' telephone number is (617) 370-8837.

In which U.S. state is Relay Therapeutics incorporated?

Relay Therapeutics is incorporated in Delaware.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 6, 2025 regarding Relay Therapeutics, Inc. (RLAY).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.